Recombinant Escherichia coli O139:H28 APT Protein，His & Myc

The study of APT (Adenylate Phosphoryltransferase) recombinant proteins has gained considerable attention in recent years due to their pivotal role in various biological processes and potential therapeutic applications. APTs are essential enzymes involved in nucleotide metabolism, facilitating the transfer of phosphate groups, which is crucial for energy production and signal transduction in cells. With advances in biotechnology, scientists have been able to engineer recombinant APT proteins, allowing for a detailed examination of their structure-function relationships. This research not only enhances our understanding of enzymatic mechanisms but also paves the way for the development of novel drugs and diagnostic tools targeting diseases linked to metabolic dysregulation. Moreover, the ability to produce APTs in heterologous systems, such as bacteria or yeast, has made it possible to obtain these proteins in large quantities, facilitating biochemical assays and structural studies. By investigating the variations in recombinant APTs derived from different organisms, researchers aim to uncover evolutionary adaptations and optimize enzyme performance for industrial applications. Overall, the exploration of APT recombinant proteins holds significant promise for advancing both fundamental and applied sciences.